MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s11606-026-10221-z

Медицинская библиотека · Journal of general internal medicine · 2026

Patient Profiles of Buprenorphine Initiators in General Healthcare Settings: A Latent Class Approach.

Grucza Richard A, Salas Joanne, Xu Kevin Y, Bello Jennifer K, Gebauer Sarah C, Veeramachaneni Kirti, Rottnek Fred, Scherrer Jeffrey F

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Buprenorphine is the most commonly used medication for treating opioid use disorder (OUD). It may also be beneficial for individuals with chronic pain who are physically dependent on opioids but do not meet the criteria for OUD. Therefore, the buprenorphine patient population may be heterogeneous in terms of OUD and comorbidities.

OBJECTIVES

To characterize the heterogeneity of patient profiles among those initiating buprenorphine treatment in a large multi-state healthcare system, focusing on comorbid pain, psychiatric, and substance use disorder diagnoses, and other patient characteristics associated with profiles.

DESIGN

Retrospective cohort study using electronic health record data.

PARTCIPIPANTS: Patients with at least 12 months of data before a new buprenorphine prescription (OUD formulation) and at least 6 months of follow-up.

MAIN MEASURES: Presence vs absence of opioid use disorder diagnoses and latent class profiles of comorbid diagnoses and clinical characteristics. Post-index outcomes, including the number of buprenorphine orders and incidence of drug-related poisoning, were assessed for each class.

KEY

RESULTS

In a cohort of 5726 individuals (mean age 38.6 years, 56.2% female, 84.0% white), four latent classes were identified: (1) high multimorbidity burden; (2) moderate multimorbidity burden; (3) high rates of comorbid pain diagnoses but lower rates of psychiatric and substance use disorder diagnoses, with most patients lacking opioid use disorder diagnoses; (4) lower rates of pain diagnoses but high rates of comorbid psychiatric and substance use disorder diagnoses. Post-index measures aligned well with comorbidity profiles.

CONCLUSION

Patients receiving buprenorphine in general healthcare settings likely form a heterogeneous group. This includes a subgroup with low rates of opioid use disorder diagnoses (class 2, pain comorbidity), who may resemble chronic pain patients more than conventional OUD patients.

Для цитирования: Grucza Richard A, Salas Joanne, Xu Kevin Y, Bello Jennifer K, Gebauer Sarah C, Veeramachaneni Kirti, Rottnek Fred, Scherrer Jeffrey F. Patient Profiles of Buprenorphine Initiators in General Healthcare Settings: A Latent Class Approach.. Journal of general internal medicine. 2026. DOI: 10.1007/s11606-026-10221-z.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.